Jasper Ridge Partners’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-663
Closed -$364K 147
2022
Q1
$364K Hold
663
0.02% 121
2021
Q4
$438K Hold
663
0.02% 121
2021
Q3
$556K Hold
663
0.02% 119
2021
Q2
$841K Hold
663
0.04% 99
2021
Q1
$727K Hold
663
0.03% 91
2020
Q4
$946K Hold
663
0.04% 83
2020
Q3
$468K Hold
663
0.03% 92
2020
Q2
$464K Hold
663
0.03% 84
2020
Q1
$232K Hold
663
0.02% 90
2019
Q4
$417K Buy
+663
New +$324K 0.03% 79

Other funds holding CDLX

Jasper Ridge Partners's CDLX Position: Q2 2022 in Review

Jasper Ridge Partners sold out of Cardlytics (CDLX) in Q2 2022, closing a stake of 663 shares — an estimated $364K sold.

Jasper Ridge Partners first reported a position in CDLX in Q4 2019 and held it in 10 quarters. The position peaked at $946K in Q4 2020. 138 funds tracked by Wall St. Rank hold CDLX as of Q2 2022.

  • Jasper Ridge Partners reported no remaining Cardlytics position as of Q2 2022 after selling out during the quarter.
  • Jasper Ridge Partners sold 663 Cardlytics shares in Q2 2022, an estimated $364K.
  • Jasper Ridge Partners first reported a position in Cardlytics in Q4 2019 and held it in 10 quarters.
  • Jasper Ridge Partners's Cardlytics position peaked at $946K in Q4 2020.
  • 138 funds tracked by Wall St. Rank held Cardlytics as of Q2 2022.

Based on Jasper Ridge Partners's 13F filing for Q2 2022, filed 15 Aug 2022.